...

WHERE WE DO iT

We are truly global and really local. Our policy work and shaping abilities span all regions, from North, Central and South America, the Caribbean, Europe, the Middle East and Africa, to Asia and Australia. We shape policies in cities, provinces, states, countries, regions and globally. Our combined experience covers more than 150 countries around the world.

We maintain a strong core team of seasoned professionals in key areas who are familiar with the issues and market conditions that impact the health system. Through our business partnership approach, and through our consultants’ use of our methodologies, we can provide our clients with local expertise to work on the issues that impact their business in the specific countries in which they operate.

Show/hide countries list
  • Northern America
  • Bermuda
  • Canada
  • Mexico
  • United States
  • Central America
  • Belize
  • Costa Rica
  • El Salvador
  • Guatemala
  • Honduras
  • Nicaragua
  • Panama
  • South America
  • Argentina
  • Bolivia
  • Brazil
  • Chile
  • Colombia
  • Ecuador
  • French Guiana
  • Guyana
  • Paraguay
  • Peru
  • Suriname
  • Uruguay
  • Venezuela
  • The Caribbean
  • Anguilla
  • Antigua and Barbuda
  • Aruba
  • Bahamas
  • Barbados
  • Bonaire
  • British Virgin Islands
  • Cayman Islands
  • Cuba
  • Curaçao
  • Dominica
  • Dominican Republic
  • Grenada
  • Guadeloupe
  • Haiti
  • Jamaica
  • Martinique
  • Monserrat
  • Puerto Rico
  • Saint-Barthélemy
  • Saint Lucia
  • Saint Kitts and Nevis
  • Saint Maarten
  • Saint Vincent and the Grenadines
  • Trinidad and Tobago
  • Turks and Caicos Islands
  • Virgin Islands (US)
  • Africa
  • Angola
  • Argelia
  • Botswana
  • Burkina Faso
  • Cameroon
  • Central African Republic
  • Chad
  • Egypt
  • Eritrea
  • Ethiopia
  • Ghana
  • Guinea
  • Guinea Bissau
  • Ivory Coast
  • Kenya
  • Libya
  • Madagascar
  • Malawi
  • Mali
  • Morocco
  • Mozambique
  • Namibia
  • Niger
  • Nigeria
  • Rwanda
  • Senegal
  • South Africa
  • Sudan
  • Tanzania
  • Togo
  • Tunisia
  • Uganda
  • Zambia
  • Zimbabwe
  • Middle East
  • Israel
  • Jordan
  • Oman
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Europe
  • Albania
  • Austria
  • Andorra
  • Azerbaijan
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macedonia
  • Malta
  • Monaco
  • Montenegro
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Russia
  • San Marino
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • Asia
  • Bangladesh
  • Bhutan
  • Brunei
  • Cambodia
  • China
  • Hong Kong
  • India
  • Indonesia
  • Japan
  • Laos
  • Malaysia
  • Myanmar
  • Mongolia
  • Nepal
  • Papua New Guinea
  • Philippines
  • Singapore
  • South Korea
  • Sri Lanka
  • Taiwan
  • Thailand
  • Vietnam
  • Oceania
  • Australia
  • New Zealand

OUR EXPERiENCE

iSSUES

  • Access to Medicines
  • Adoption of Innovations
  • Anti-microbial Resistance
  • Behavioral Economics/Decision Biases
  • Clinical Guideline Development
  • Digital Health
  • Drug Pricing
  • Essential Medicines
  • Health as a Human Right
  • Health Budgets/Financing
  • Health Care Reform
  • Health Equity/Disparities
  • Health Insurance
  • Health Lawsuits
  • Health Literacy
  • Health Systems Resiliency
  • Health Systems Strengthening
  • Health Technology Assessments
  • Healthcare Sustainability
  • Healthy Aging
  • Hospital Management
  • Intellectual Property
  • Models of Care
  • Patient Centricity
  • Personalized Medicines
  • Pharma and Biotech Investment
  • Life Course Approach
  • Pooled Procurement
  • Pricing and Transparency
  • Product Life Cycle
  • Procurement of Biologics
  • Regulatory and Reimbursement Policies
  • Regulatory Harmonization
  • Regulatory Resiliency
  • Science of Patient Input
  • Social Determinants of Health
  • Substandard & Counterfeit Medicines
  • Sustainable Development Goals
  • Universal Health Coverage
  • Value-Based Healthcare
  • Value of Cures
  • Value of Prevention
  • Supply Chain Implications
  • Sustainable Healthcare
  • Pandemic Preparedness

NON-COMUNiCABLE DiSEASES

  • Cardiovascular Disease
  • Respiratory Disease
  • Diabetes
  • Cancers
  • Rare Diseases
  • Autoimmune Diseases
  • Mental Health Disorders
  • Degenerative Disease

iNFECTIOUS DiSEASES

  • COVID-19
  • Dengue
  • Group B Streptococcus
  • Hepatitis
  • HIV/AIDS
  • Human Papillomavirus Influenza
  • Malaria
  • Meningococcal Disease
  • Pneumococcus
  • Rotavirus
  • Shingles
  • Tuberculosis

PRODUCTS

  • Biologics
  • Biosimilars
  • Diagnostics
  • Generics
  • Medical Devices
  • Plasma Therapies
  • Prefilled Syringes
  • Theragnostics
  • Vaccines

OUR CLiENTS

We have helped over 60 clients to address and overcome their challenges and maximize their opportunities.

PHARMACEUTICAL COMPANIES
PATIENT ADVOCACY GROUPS (PAGs)
NGOs & ACADEMIA
MEDICAL DEVICES
GOVERNMENT AGENCIES
INSURANCE COMPANIES
TRADE ASSOCIATIONS
FOOD & NUTRITION
COMMUNICATION AGENCIES